Posts from ‘August, 2010’

Patented Technology Used in Aortic and Peripheral Vascular Applications IRVINE, Calif., Aug. 16 (HSMN NewsFeed) — Endologix, Inc. (Nasdaq:ELGX ), developer of minimally invasive treatments for aortic disorders, announced today that it has entered int…
Devices, Interventional Cardiology, Licensing
Endologix, Evasc Clinical Systems, cobalt chromium, balloon expandable stent

MORRISTOWN, N.J., Aug. 13 (HSMN NewsFeed) — Watson Pharmaceuticals, Inc. (NYSE:WPI ), today announced that it intends to launch ella® (ulipristal acetate), a novel oral emergency contraceptive, in the fourth quarter of 2010. Watson’s announcement f…
Biopharmaceuticals, FDA
Watson Pharmaceuticals, HRA Pharma, ella , emergency contraceptive

Novel Emergency Contraceptive Developed by HRA Pharma to be Marketed by Watson Pharmaceuticals in the US Before the end of 2010 PARIS, August 13, 2010 (HSMN NewsFeed) — HRA Pharmaceutical announced today that the US Food and Drug Administration (FDA) grante…
Biopharmaceuticals, FDA
HRA Pharma, Watson Pharmaceuticals, ella , emergency contraceptive

$35 million agreement combines expertise and passion of 2 leading-edge specialty pharmaceutical companies LOUISVILLE, Ky., Aug. 13 (HSMN NewsFeed) — US WorldMeds, LLC, a Kentucky-based specialty lab company that develops unique products…
Biopharmaceuticals, Neurology, Mergers & Acquisitions
US WorldMeds, Solstice Neurosciences, MYOBLOC, rimabotulinumtoxinB

Experienced Pulmonologist and Cystic Fibrosis Drug Development Expert Joins Inspire DURHAM, N.C.–(Healthcare Sales & Marketing Network)–Inspire Pharmaceuticals, Inc. (NASDAQ: ISPH ) announced today it has entered into an Executive Employment Agreement…
Biopharmaceuticals, Personnel
Inspire Pharmaceuticals

Medical evaluation of a revolutionary new device technology for the treatment of vascular disease has begun BUELACH, Switzerland–(Healthcare Sales & Product management Network)–A significant milestone has been reached in the development of a new therapy for p…
Devices, Interventional Cardiology
BIOTRONIK, BIOTRONIK DREAMS, Drug Eluting Absorbable Metal Scaffold

Lilly Plans Appeal to Defend Strattera’s Intellectual Property INDIANAPOLIS, Aug. 12 (HSMN NewsFeed) — Eli Lilly and Company (NYSE:LLY ) today announced that the U.S. District Court for the District of New Jersey has ruled against the company in its…
Biopharmaceuticals, Generics, Litigation
Eli Lilly, Strattera, atomoxetine

MOUNTAIN VIEW, Calif., Aug. 12 (HSMN NewsFeed) — Alexza Pharmaceuticals, Inc. (Nasdaq:ALXA ) announced today that Darl Moreland has joined the company as Vice President, Quality. He will have responsibility for Quality Assurance, Quality Control and Q…
Biopharmaceuticals, Personnel
Alexza Pharmaceuticals

MINNEAPOLIS–(Healthcare Sales & Marketing Network)–Medtronic, Inc. (NYSE: MDT ) today announced it has completed its acquisition of ATS Pathology, Inc. following payment of $4.00 per share in cash for each share of ATS Clinical stock and assumption of net d…
Devices, Cardiology, Mergers & Acquisitions
Medtronic, ATS Clinical

New Orthopaedic Trauma Product to Revolutionize Periprosthetic Fracture Care WARSAW, Ind., Aug. 11 (HSMN NewsFeed) — Zimmer Holdings, Inc. (NYSE: ZMH; SIX: ZMH), a global leader in musculoskeletal care, today announced the first implantation of the Z…
Devices, Orthopaedic
Zimmer Holdings, Periprosthetic Plating System